Phase II study of Troxatyl ™ in patients with chronic myeloid leukemia in blastic phase (CML-BP).

被引：0
|
作者：
Giles, F
Feldman, E
Cortes, J
Faderl, S
Larson, R
Mamus, S
Thomas, D
Garcia-Manero, G
O'Brien, S
Beran, M
Talpaz, M
Kantarjian, H
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Cornell Univ, New York, NY USA
[3] Univ Chicago, Canc Res Ctr, Chicago, IL USA
[4] Univ Texas, MD Anderson Canc Ctr, Orlando, FL USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4764
引用
收藏
页码：258B / 258B
页数：1
相关论文
共 50 条
  • [11] Rare Blast Phase (BP) Phenotypes of Chronic Myeloid Leukemia (CML)
    Ghanem, Hady
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Cortes, Jorge E.
    Quintas-Cardama, Alfonso
    BLOOD, 2012, 120 (21)
  • [12] Diagnosis of Blastic Phase of Chronic Myeloid Leukemia
    Stagno, Fabio
    Vigneri, Paolo
    Cupri, Alessandra
    Vitale, Silvia Rita
    Di Raimondo, Francesco
    ACTA HAEMATOLOGICA, 2012, 127 (04) : 198 - 198
  • [13] Results of a phase II study of STI in adults patients with Philadelphia chromosome positive Chronic Myeloid Leukemia in Chronic Phase (CML).
    Guilhot, F
    Kantarjian, H
    Sawyers, C
    Hochhaus, A
    Schiffer, C
    Resta, D
    Capdeville, R
    Druker, B
    LEUKEMIA, 2001, 15 (03) : 488 - 488
  • [14] An Open-Label, Phase I Study of Dasatinib in Combination with Decitabine in Patients (Pts) with Accelerated or Blastic Phase Chronic Myeloid Leukemia (CML)
    Abaza, Yasmin
    Kantarjian, Hagop M.
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Daver, Naval
    Ravandi, Farhad
    Verstovsek, Srdan
    Burger, Jan A.
    Estrov, Zeev
    Ohanian, Maro
    Lim, Miranda
    Assi, Rita
    Jabbour, Elias J.
    Cortes, Jorge E.
    BLOOD, 2016, 128 (22)
  • [15] Imatinib (Glivec®) in patients with Ph plus chronic myeloid leukemia in accelerated/blastic phase (AP/B):: Results of a phase II trial of the Italian Cooperative Study Group on CML (ICSG on CML).
    Trabacchi, E
    Bonifazi, F
    Bassi, S
    Testoni, N
    Alberti, D
    De Vivo, A
    Saglio, G
    Pane, F
    Martinelli, G
    Amabile, M
    Giannini, B
    Ottaviani, E
    Tura, S
    Rosti, G
    Baccarani, M
    BLOOD, 2002, 100 (11) : 584A - 584A
  • [16] An Open-Label, Phase I Study of Dasatinib in Combination with Decitabine in Patients (Pts) with Accelerated or Blastic Phase Chronic Myeloid Leukemia (CML)
    Abaza, Yasmin
    Kantarjian, Hagop M.
    Borthakur, Gautam
    Daver, Naval
    Ravandi, Farhad
    Chihara, Dai
    Verstovsek, Srdan
    Burger, Jan A.
    Estrov, Zeev
    Ohanian, Maro
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2015, 126 (23)
  • [17] IMMUNOPHENOTYPE OF CHRONIC MYELOID-LEUKEMIA BLASTIC PHASE
    LOPEZKARPOVITCH, X
    CARDENAS, MR
    PIEDRAS, J
    BLOOD, 1994, 84 (10) : A633 - A633
  • [18] Accelerated and blastic phase of chronic myeloid leukemia.
    Dutcher J.P.
    Wiernik P.H.
    Current Treatment Options in Oncology, 2000, 1 (1) : 51 - 62
  • [19] High dose cladribine (2CDA) therapy for chronic myelogenous leukemia in blast phase (CML-BP).
    Dann, EJ
    Anastasi, J
    Larson, RA
    BLOOD, 1996, 88 (10) : 928 - 928
  • [20] Prognostic Factors in the Blastic and Accelerated Phase of Patients with Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era
    Chae, Young Kwang
    Kantarjian, Hagop M.
    Romo, Carlos G.
    Whitaker, Clay
    Jabbour, Elias J.
    O'Brien, Susan
    Borthakur, Gautam
    Ravandi, Farhad
    Thomas, Deborah A.
    Pierce, Sherry A.
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
12345